The Business Research Company credits oral peptides, personalized obesity care and wider reimbursement for the projected growth. A promotional forecast.
Recap by typeshit. Post by The Business Research Company on X.
Costco is adding Novo Nordisk's semaglutide shots to what it offers. Details are thin here, so tap through for how pricing and access will work.
An explainer on talking to a provider about whether Wegovy fits you, plus a reminder that insurance may not pay for it.
Khunti shares real-world data on over a million UK adults using telehealth for obesity care, where 90% started on tirzepatide before a major price hike changed prescribing.
Polskie Radio reports a Wegovy price cut in China, coming soon after the drug's approval there. Tap through for the details.
Fallon says semaglutide and tirzepatide pull in about 60% of the combined run rate revenue of Anthropic and OpenAI, at a sixth of the reach.
Lilly is expected to file with the FDA in early 2027. The piece also covers trial weight loss near 30% and warnings about gray-market vials sold as research only.
Loading…